Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compugen (CGEN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Compugen (CGEN) over the last 15 years, with Q3 2025 value amounting to $7.5 million.

  • Compugen's Cash & Equivalents rose 331.21% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 331.21%. This contributed to the annual value of $18.2 million for FY2024, which is 3123.83% up from last year.
  • Compugen's Cash & Equivalents amounted to $7.5 million in Q3 2025, which was up 331.21% from $6.5 million recorded in Q2 2025.
  • Compugen's Cash & Equivalents' 5-year high stood at $18.2 million during Q4 2024, with a 5-year trough of $6.5 million in Q2 2025.
  • For the 5-year period, Compugen's Cash & Equivalents averaged around $11.3 million, with its median value being $11.1 million (2022).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 11317.43% in 2023, then plummeted by 4555.02% in 2025.
  • Quarter analysis of 5 years shows Compugen's Cash & Equivalents stood at $8.5 million in 2021, then grew by 29.68% to $11.1 million in 2022, then rose by 25.6% to $13.9 million in 2023, then soared by 31.24% to $18.2 million in 2024, then tumbled by 59.1% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $6.5 million for Q2 2025, and $14.6 million during Q1 2025.